Back

Alternans of the atrial posterior wall pulmonary vein junction as a driver for atrial fibrillation and a target for pharmacological therapy

30 August 2026 (08:15 - 09:00)
Organised by: Logo
Congress Presentation Part of: Atrial fibrillation ablation: mechanisms, procedural innovation, and clinical outcomes Cellular Mechanisms of Arrhythmias ESC2026 Premium Access ESC Congress 2026 European Society of Cardiology

About the speaker

Photo
Miss Menglu Lin

University of Manchester, Manchester (United Kingdom of Great Britain & Northern Ireland)

7 More presentations in this session

Presentation thumbnail
Esophageal safety of pulsed field versus radiofrequency ablation including posterior wall isolation in persistent atrial fibrillation: a blinded endoscopic study
Doctor L. Aguinaga Arrascue (Tucuman, AR)
Abstract Slides Video
Presentation thumbnail
A completely fluoroscopy-free approach for pulmonary vein isolation including electroanatomically guided transseptal puncture without TEE, ICE or general anesthesia
Doctor T. Wolber (Zurich, CH)
Abstract Slides Video
Presentation thumbnail
A faster, optimized pulsed field timing sequence demonstrates safety under aggressive lesion stacking without evidence of electrode heating
Doctor A. Amin (Columbus, US)
Abstract Slides Video
Presentation thumbnail
Pulsed field versus thermal ablation for atrial fibrillation: a systematic review and meta-analysis of efficacy, safety and procedural performance
Doctor A. Campos Munoz (MX)
Abstract Slides Video
Presentation thumbnail
Proof of concept - retrospective virtual reality pulmonary veins modeling evaluating eligibility for atrial fibrillation cryoballoon ablation
Doctor D. Hochstein (Ramat Gan, IL)
Abstract Slides Video

Access the full session

Session thumbnail
Atrial fibrillation ablation: mechanisms, procedural innovation, and clinical outcomes

The Event

Event poster

ESC Congress 2026

30 August 2026 08:15 CET
You may be interested in
thumbnail
Congress Presentation
Characterization of paroxysmal atrial fibrillation in atrial septal defects: contribution of a left atrial substrate
12 April 2026
thumbnail
Congress Presentation
Acute in vivo antiarrhythmic effects of cGMP-modifying drugs in the R2474S mouse model of catecholiminergic polymorphic ventricular tachycardia.
30 March 2025
thumbnail
Congress Presentation
Mechanisms underlying alternans and oscillation during sustain VT: insights from high density mapping of the isthmus
14 April 2026
thumbnail
Congress Presentation
Investigation of the antiarrhythmic effect of Na+/Ca2+ exchanger inhibition in cardiac cells
1 May 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources